Fingerprint
Dive into the research topics where Hesham Amin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma
Eid, J., Haddad, A., Hassan, M., Amin, H. M., Newhook, T. E., Chun, Y. S., Tzeng, C. W. D., Vauthey, J. N., Tran Cao, H. S. & Kaseb, A. O., Jan 2026, In: Journal of Gastrointestinal Surgery. 30, 1, 102275.Research output: Contribution to journal › Article › peer-review
Open Access -
Growth Hormone Pathway as a Prognostic and Therapeutic Biomarker in Patients With Unresectable Hepatocellular Carcinoma Treated With Radiation Therapy
Eid, J. R., Kaseb, S., Xiao, L., Sun, R., Kannan, M. K., Hassan, M., Rashid, A., Cao, H. S. T., Amin, H. M. & Koay, E. J., May 2026, In: Advances in Radiation Oncology. 11, 5, 102007.Research output: Contribution to journal › Article › peer-review
Open Access -
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma
Eid, J. R., Yalciner, M., Xiao, L., Sun, R., Kannan, M. K., Hassan, M., Rashid, A., Chamseddine, S., Tran Cao, H. S., Amin, H. M. & Kaseb, A. O., 2025, In: Journal of Hepatocellular Carcinoma. 12, p. 2709-2722 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluating the role of preoperative plasma insulin-like growth factor 1 (IGF-1) as a predictor of survival and recurrence in patients with resectable hepatocellular carcinoma.
Eid, J., Haddad, A., Lee, S. S., Hu, Z., Hassan, M. M., Amin, H., Newhook, T. E., Tzeng, C. W. D., Vauthey, J. N., Chun, Y. S., Singer, E. D., Tran Cao, H. S. & Kaseb, A. O., Jun 2025, In: Journal of Clinical Oncology. 43, p. e16318-e16318Research output: Contribution to journal › Article › peer-review
-
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma
Lapelusa, M., Chamseddine, S., Tran Cao, H. S., Xiao, L., Hasanov, E., Bhosale, P., Amin, H. M., Mohamed, Y. I., Gok Yavuz, B., Sakr, Y., Xu, L., Hu, I., Lee, S. S., Sakamuri, D., Jindal, S., Nguyen, V., Curran, M. A., Sun, R., Rashid, A. & Duda, D. G. & 3 others, , May 1 2025, In: Oncology (Switzerland). 103, 6, p. 490-497 8 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations